Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
US FDA approves Tagrisso as 1st-line treatment for EGFR-mutated non-small cell lung cancer
-
Updated overall survival data for Lynparza in BRCA-mutated HER2-negative metastatic breast cancer presented at AACR
-
1st-line Tagrisso demonstrates sustained benefit post progression in patients with EGFR-mutated non-small cell lung cancer
-
AstraZeneca’s early and late-stage oncology portfolio showcased at AACR annual meeting and ELCC
-
US FDA accepts Biologics License Application for moxetumomab pasudotox in hairy cell leukaemia
-
The European Medicines Agency accepts regulatory submission for Lynparza in BRCA-mutated HER2-negative metastatic breast cancer
-
Lokelma approved in the EU for the treatment of adults with hyperkalaemia
-
AstraZeneca provides update on MYSTIC trial timeline
-
New data from landmark CVD-REAL study of patients with type-2 diabetes confirms CV benefits associated with SGLT-2 Inhibitors
-
The European Medicines Agency accepts regulatory submission for Forxiga in adults with type-1 diabetes
Latest articles and press releases
All of our latest press releases and articles are available to explore
